6,678 trials
Sleep Disorders
Primary: Change in Pittsburgh Sleep Quality Index — -0.86; -3.15; -3.32 difference score of PSQI total
Carcinoma, Large Cell · Neuroendocrine Tumors
Primary: Percentage of Participants Progression-free — 49.0 Percentage of participants
Dental Plaque · Gingivitis
Primary: Dental Plaque Scores — 3.91; 3.86; 3.84 units on a scale — p=0.652
Dental Plaque · Gingivitis
Primary: Dental Plaque Scores — 3.33; 3.22; 3.34 units on a scale — p=0.04
Psoriasis · Atopic Dermatitis
Primary: Post-injection Serum Cortisol Level — 1 participants
Platelet Aggregation Inhibitors · Coronary Heart Disease
Primary: Changes in Platelet Function in Response to Clopidogrel — 38.51; 14.06 percentage of maximum aggregation change
Postoperative Pain · Inflammation
Primary: Numerical Rating Scale (NRS) Pain Score — 5.8; 7.4; 7.4; 8.8 score on a scale
Hypertension
Primary: Plasma Nitric Oxide Level Change From Baseline to Month 12 Between the Groups. — 11.47; -17.27 percent change
Ageing
Primary: Evaluate Overall Facial Improvement Assessed Live by the Investigator and Subjects Using the Global Aesthetic Improvement Scale (GAIS) at 12 Weeks Compared to Baseline…
Rheumatoid Arthritis
Primary: The Percentage of Subjects With Clinical Response at Week 12 Who Also Had Clinical Response at Week 52 — 69.1 percentage of subjects
Hernia, Inguinal
Primary: Change From Baseline in Activities Assessment Scale at 3 Months — -7.49; -6.12 units on a scale
Parkinson's Disease
Primary: Mean Change From Baseline to Week 24 in the Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-COG) Summary Score — 1.6; 0.8 units on a scale — p=0.2204
Postoperative Pain
Primary: Proportion of Patients Who Experienced Moderate to Severe Pain During First and Second Postoperative Day — 8.3; 80.8; 4.2; 42.3 percentage of patients
Postoperative Nausea and Vomiting
Primary: PONV During the First 24 Hours After Bariatric Surgery — 22; 12 participants — p=0.04
Major Depression
Primary: Montgomery-Asberg Depression Rating Scale (MARDS) Score (Acute Response to IV Ketamine in Patients With Treatment Resistant Major Depression) — 24.4; 22.0 scores on a…